Literature DB >> 30059710

Control of SUMO and Ubiquitin by ROS: Signaling and disease implications.

Nicolas Stankovic-Valentin1, Frauke Melchior2.   

Abstract

Reversible post-translational modifications (PTMs) ensure rapid signal transmission from sensors to effectors. Reversible modification of proteins by the small proteins Ubiquitin and SUMO are involved in virtually all cellular processes and can modify thousands of proteins. Ubiquitination or SUMOylation is the reversible attachment of these modifiers to lysine residues of a target via isopeptide bond formation. These modifications require ATP and an enzymatic cascade composed of three classes of proteins: E1 activating enzymes, E2 conjugating enzymes and E3 ligases. The reversibility of the modification is ensured by specific isopeptidases. E1 and E2 enzymes, some E3 ligases and most isopeptidases have catalytic cysteine residues, which make them potentially susceptible for oxidation. Indeed, an increasing number of examples reveal regulation of ubiquitination and SUMOylation by reactive oxygen species, both in the context of redox signaling and in severe oxidative stress. Importantly, ubiquitination and SUMOylation play essential roles in the regulation of ROS homeostasis, participating in the control of ROS production and clearance. In this review, we will discuss the interplay between ROS homeostasis, Ubiquitin and SUMO pathways and the implications for the oxidative stress response and cell signaling.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cysteine oxidation; NADPH oxidase; Oxidative stress; Redox signaling; SUMO; Ubiquitin

Mesh:

Substances:

Year:  2018        PMID: 30059710     DOI: 10.1016/j.mam.2018.07.002

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  21 in total

1.  Wss1 homolog from Candida albicans and its role in DNA-protein crosslink tolerance.

Authors:  Aimorn Homchan; Juthamas Sukted; Skorn Mongkolsuk; David Jeruzalmi; Oranart Matangkasombut; Danaya Pakotiprapha
Journal:  Mol Microbiol       Date:  2020-05-13       Impact factor: 3.501

Review 2.  TRIMs: Generalists Regulating the NLRP3 Inflammasome Signaling Pathway.

Authors:  Nian-Hua Deng; Zhi-Xiang Zhou; Hui-Ting Liu; Zhen Tian; Ze-Fan Wu; Xi-Yan Liu; Wen-Hao Xiong; Zuo Wang; Zhi-Sheng Jiang
Journal:  DNA Cell Biol       Date:  2022-02-18       Impact factor: 3.311

3.  Disturbed flow-induced FAK K152 SUMOylation initiates the formation of pro-inflammation positive feedback loop by inducing reactive oxygen species production in endothelial cells.

Authors:  Loka Reddy Velatooru; Rei J Abe; Masaki Imanishi; Young Jin Gi; Kyung Ae Ko; Kyung-Sun Heo; Keigi Fujiwara; Nhat-Tu Le; Sivareddy Kotla
Journal:  Free Radic Biol Med       Date:  2021-10-05       Impact factor: 7.376

4.  Proteasome lid bridges mitochondrial stress with Cdc53/Cullin1 NEDDylation status.

Authors:  L Bramasole; A Sinha; S Gurevich; M Radzinski; Y Klein; N Panat; E Gefen; T Rinaldi; D Jimenez-Morales; J Johnson; N J Krogan; N Reis; D Reichmann; M H Glickman; E Pick
Journal:  Redox Biol       Date:  2018-11-17       Impact factor: 11.799

5.  Monitoring structural modulation of redox-sensitive proteins in cells with MS-CETSA.

Authors:  Wendi Sun; Lingyun Dai; Han Yu; Brenda Puspita; Tianyun Zhao; Feng Li; Justin L Tan; Yan Ting Lim; Ming Wei Chen; Radoslaw M Sobota; Daniel G Tenen; Nayana Prabhu; Pär Nordlund
Journal:  Redox Biol       Date:  2019-03-14       Impact factor: 11.799

Review 6.  The SUMO Pathway in Hematomalignancies and Their Response to Therapies.

Authors:  Mathias Boulanger; Rosa Paolillo; Marc Piechaczyk; Guillaume Bossis
Journal:  Int J Mol Sci       Date:  2019-08-09       Impact factor: 5.923

7.  The ubiquitin-like modifier FAT10 interferes with SUMO activation.

Authors:  Annette Aichem; Carolin Sailer; Stella Ryu; Nicola Catone; Nicolas Stankovic-Valentin; Gunter Schmidtke; Frauke Melchior; Florian Stengel; Marcus Groettrup
Journal:  Nat Commun       Date:  2019-10-01       Impact factor: 14.919

8.  RNF34 overexpression exacerbates neurological deficits and brain injury in a mouse model of intracerebral hemorrhage by potentiating mitochondrial dysfunction-mediated oxidative stress.

Authors:  Xin Qu; Ning Wang; Wenjin Chen; Meng Qi; Yueqiao Xue; Weitao Cheng
Journal:  Sci Rep       Date:  2019-11-08       Impact factor: 4.379

Review 9.  Gestational Hypoxia and Programing of Lung Metabolism.

Authors:  Kristiana Rood; Vanessa Lopez; Michael R La Frano; Oliver Fiehn; Lubo Zhang; Arlin B Blood; Sean M Wilson
Journal:  Front Physiol       Date:  2019-11-29       Impact factor: 4.566

Review 10.  Current Status of SUMOylation Inhibitors.

Authors:  Christopher M Brackett; Brian S J Blagg
Journal:  Curr Med Chem       Date:  2021       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.